Your browser doesn't support javascript.
loading
Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
Ibarra-Bracamontes, Vanessa J; Escobar-Herrera, Jaime; Kristofikova, Zdena; Rípova, Daniela; Florán-Garduño, Benjamín; Garcia-Sierra, Francisco.
Afiliação
  • Ibarra-Bracamontes VJ; Department of Physiology, Biophysics and Neurosciences, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico.
  • Escobar-Herrera J; Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico.
  • Kristofikova Z; National Institute of Mental Health, Klecany, Czech Republic.
  • Rípova D; National Institute of Mental Health, Klecany, Czech Republic.
  • Florán-Garduño B; Department of Physiology, Biophysics and Neurosciences, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico.
  • Garcia-Sierra F; Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico. Electronic address: fgarcia-sierra@cell.cinvestav.mx.
Brain Res ; 1744: 146953, 2020 10 01.
Article em En | MEDLINE | ID: mdl-32526294
In Alzheimer's disease, tau protein undergoes post-translational modifications including hyperphosphorylation and truncation, which promotes two major conformational changes associated with progressive N-terminal folding. Along with the development of the disease, tau ubiquitination was previously shown to emerge in the early and intermediate stages of the disease, which is closely associated with early tau truncation at aspartic acid 421, but not with a subsequently truncated tau molecule at glutamic acid 391. In the same group of cases, using multiple immunolabeling and confocal microscopy, a possible relationship between the ubiquitin-targeting of tau and the progression of conformational changes adopted by the N-terminus of this molecule was further studied. A comparable number of neurofibrillary tangles was found displaying ubiquitin, an early conformation recognized by the Alz-50 antibody, and a phosphorylation. However, a more reduced number of neurofibrillary tangles were immunoreactive to Tau-66 antibody, a late tau conformational change marker. When double-labeling profiles of neurofibrillary tangles were assessed, ubiquitination was clearly demonstrated in tau molecules undergoing early N-terminal folding, but was barely observed in late conformational changes of the N-terminus adopted by tau. The same pattern of colocalization was visualized in neuritic pathology. Overall, these results indicate that a more intact conformation of the N-terminus of tau may facilitate tau ubiquitination, but this modification may not occur in a late truncated and more compressed folding of the N-terminus of the tau molecule.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Emaranhados Neurofibrilares / Proteínas tau / Ubiquitinação / Doença de Alzheimer Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: México País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Emaranhados Neurofibrilares / Proteínas tau / Ubiquitinação / Doença de Alzheimer Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: México País de publicação: Holanda